纳米粒子介导的细胞烧灭:一种新的治疗策略,用于炎症性疾病和癌症
Lin Zhao1,2, Haipeng Cheng1,2, Zhongyi Tong1,2
1Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China.
Journal of nanobiotechnology
|August 22, 2024
概括
纳米材料可以诱导癌症治疗的热亡 (编程细胞死亡),但过度的炎症是一个风险. 这篇评论探讨了基于纳米粒子的癌症和炎症疾病的热灭治疗方法.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 免疫学 免疫学 免疫学
背景情况:
- 热症是一种由气体皮质介导的性细胞死亡形式,导致细胞胀和破裂.
- 在癌细胞中诱导热致死增强了抗瘤免疫力,呈现出有前途的癌症治疗策略.
- 过度的热可以导致由于不受控制的炎症反应引起的炎症性疾病.
研究的目的:
- 审查基于纳米粒子的灭治疗癌症和炎症疾病的进展.
- 专注于纳米药物在诱导和操纵热的功能和机制.
- 提供对选择纳米药物用于热的见解,并讨论未来的前景.
主要方法:
- 关于用于诱导热的纳米材料和纳米生物技术的当前文献的综述.
- 对用于癌症治疗的基于纳米粒子的药物输送系统的分析.
- 讨论纳米医药诱导的热的机制.
主要成果:
- 纳米材料在诱导热的过程中具有独特的优势,克服了小分子的局限性.
- 纳米输送系统可以直接诱导和控制癌细胞中的灭.
- 基于纳米粒子的策略在治疗癌症和炎症疾病方面显示出潜力.
结论:
- 基于纳米颗粒的热诱导是癌症和炎症疾病的有前途的治疗策略.
- 进一步了解纳米生物相互作用对于临床转化至关重要.
- 新兴的型纳米材料在医学中具有显著的未来潜力.
相关概念视频
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Phagocytosis of Apoptotic Cells
3.7K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
3.7K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


